Total Payments
$3,184
2024 Payments
$930.45
Companies
31
Transactions
179
Medicare Patients
2,188
Medicare Billing
$227,273
Payment Breakdown by Category
Food & Beverage$3,184 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,184 | 179 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $818.41 | 51 | $0 (2024) |
| Ardelyx, Inc. | $274.76 | 16 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $266.85 | 15 | $0 (2024) |
| PFIZER INC. | $172.29 | 12 | $0 (2024) |
| GENZYME CORPORATION | $146.52 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $134.06 | 8 | $0 (2024) |
| Gilead Sciences, Inc. | $129.83 | 6 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $123.72 | 7 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $95.91 | 6 | $0 (2023) |
| Celgene Corporation | $89.60 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $930.45 | 53 | ABBVIE INC. ($210.88) |
| 2023 | $1,161 | 63 | AbbVie Inc. ($247.74) |
| 2022 | $629.95 | 36 | ABBVIE INC. ($244.07) |
| 2021 | $462.54 | 27 | AbbVie Inc. ($115.72) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: Immunology | ||||||
| 10/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Lilly USA, LLC | OMVOH (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Rare Disease | ||||||
| 09/10/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/05/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: IMMUNOLOGY | ||||||
| 07/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Gastroenterology | ||||||
| 07/16/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Immunology | ||||||
| 07/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/17/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 931 | 1,107 | $925,440 | $96,098 |
| 2022 | 15 | 955 | 1,188 | $874,045 | $99,667 |
| 2021 | 9 | 302 | 360 | $266,965 | $31,508 |
Total Patients
2,188
Total Services
2,655
Medicare Billing
$227,273
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 119 | 120 | $249,960 | $24,195 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 199 | $43,199 | $16,139 | 37.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 138 | 138 | $254,196 | $13,753 | 5.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $30,492 | $10,208 | 33.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 91 | 92 | $123,004 | $6,678 | 5.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 137 | 268 | $38,860 | $5,638 | 14.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 24 | 24 | $27,624 | $4,036 | 14.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 28 | 29 | $77,229 | $2,994 | 3.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 54 | $7,820 | $2,948 | 37.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $17,700 | $2,933 | 16.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $24,544 | $1,985 | 8.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $23,060 | $1,750 | 7.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,429 | $1,217 | 35.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,267 | $1,112 | 34.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,056 | $512.76 | 48.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 179 | 254 | $49,022 | $22,149 | 45.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 103 | 104 | $216,632 | $19,280 | 8.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 151 | 151 | $278,142 | $14,964 | 5.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 110 | 110 | $33,660 | $11,705 | 34.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 132 | 271 | $39,605 | $6,159 | 15.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 35 | 35 | $40,285 | $5,891 | 14.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 70 | 74 | $98,938 | $4,509 | 4.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 55 | $7,150 | $2,877 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $7,812 | $2,499 | 32.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 15 | 22 | $11,000 | $2,152 | 19.6% |
About Dr. Danielle Shelnut, M.D
Dr. Danielle Shelnut, M.D is a Gastroenterology healthcare provider based in Gainesville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2014. The National Provider Identifier (NPI) number assigned to this provider is 1841698867.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danielle Shelnut, M.D has received a total of $3,184 in payments from pharmaceutical and medical device companies, with $930.45 received in 2024. These payments were reported across 179 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,184).
As a Medicare-enrolled provider, Shelnut has provided services to 2,188 Medicare beneficiaries, totaling 2,655 services with total Medicare billing of $227,273. Data is available for 3 years (2021–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Gainesville, GA
- Active Since 12/08/2014
- Last Updated 07/30/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1841698867
Products in Payments
- IBSRELA (Drug) $274.76
- RINVOQ (Biological) $260.33
- XIFAXAN (Drug) $249.37
- DUPIXENT (Biological) $218.03
- HUMIRA (Biological) $185.61
- XELJANZ (Drug) $172.29
- STELARA (Biological) $166.09
- ZENPEP (Drug) $146.42
- MAVYRET (Drug) $142.52
- ZEPOSIA (Drug) $122.80
- SKYRIZI (Biological) $115.68
- VIBERZI (Drug) $78.74
- INJECTAFER (Drug) $76.12
- Sucraid (Drug) $71.96
- OCALIVA (Drug) $70.97
- OMVOH (Drug) $70.97
- ENTYVIO (Biological) $67.96
- VOQUEZNA (Drug) $62.61
- DIFICID (Drug) $47.11
- GATTEX (Drug) $38.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Gainesville
Charles Sninsky, Md, MD
Gastroenterology — Payments: $1.2M
Gastroenterology $1.2M
Peter Draganov, Md, MD
Gastroenterology — Payments: $1.1M
Gastroenterology $1.1M
Christopher Forsmark, Md, MD
Gastroenterology — Payments: $94,323
Gastroenterology $94,323
Ahmed Ouni
Gastroenterology — Payments: $31,897
Gastroenterology $31,897
Virginia Clark, Md, MD
Gastroenterology — Payments: $23,687
Gastroenterology $23,687
Dr. Roniel Cabrera, Md, MD
Gastroenterology — Payments: $22,274
Gastroenterology $22,274